These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23031259)

  • 1. Short-term akt activation in cardiac muscle cells improves contractile function in failing hearts.
    Shiojima I; Schiekofer S; Schneider JG; Belisle K; Sato K; Andrassy M; Galasso G; Walsh K
    Am J Pathol; 2012 Dec; 181(6):1969-76. PubMed ID: 23031259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT.
    Matsuda T; Jeong JI; Ikeda S; Yamamoto T; Gao S; Babu GJ; Zhai P; Del Re DP
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28193718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure.
    Schiekofer S; Shiojima I; Sato K; Galasso G; Oshima Y; Walsh K
    Physiol Genomics; 2006 Oct; 27(2):156-70. PubMed ID: 16882883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
    Streicher JM; Ren S; Herschman H; Wang Y
    Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis.
    Lauriol J; Keith K; Jaffré F; Couvillon A; Saci A; Goonasekera SA; McCarthy JR; Kessinger CW; Wang J; Ke Q; Kang PM; Molkentin JD; Carpenter C; Kontaridis MI
    Sci Signal; 2014 Oct; 7(348):ra100. PubMed ID: 25336613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ryanodine receptor type 2 is required for the development of pressure overload-induced cardiac hypertrophy.
    Zou Y; Liang Y; Gong H; Zhou N; Ma H; Guan A; Sun A; Wang P; Niu Y; Jiang H; Takano H; Toko H; Yao A; Takeshima H; Akazawa H; Shiojima I; Wang Y; Komuro I; Ge J
    Hypertension; 2011 Dec; 58(6):1099-110. PubMed ID: 21986507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
    Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
    J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.
    Shiojima I; Sato K; Izumiya Y; Schiekofer S; Ito M; Liao R; Colucci WS; Walsh K
    J Clin Invest; 2005 Aug; 115(8):2108-18. PubMed ID: 16075055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo cardiac role of migfilin during experimental pressure overload.
    Haubner BJ; Moik D; Schuetz T; Reiner MF; Voelkl JG; Streil K; Bader K; Zhao L; Scheu C; Mair J; Pachinger O; Metzler B
    Cardiovasc Res; 2015 Jun; 106(3):398-407. PubMed ID: 25852081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial S1pr1 regulates pressure overload-induced cardiac remodelling through AKT-eNOS pathway.
    Liu X; Wu J; Zhu C; Liu J; Chen X; Zhuang T; Kuang Y; Wang Y; Hu H; Yu P; Fan H; Zhang Y; Liu Z; Zhang L
    J Cell Mol Med; 2020 Jan; 24(2):2013-2026. PubMed ID: 31854513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Disintegrin and Metalloprotease-22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway.
    Ren L; Wu C; Yang K; Chen S; Ye P; Wu J; Zhang A; Huang X; Wang K; Deng P; Ding X; Chen M; Xia J
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29358191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes.
    Liu L; Zhao X; Pierre SV; Askari A
    Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1489-97. PubMed ID: 17728397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional effects of chronic Akt activation in the heart.
    Cook SA; Matsui T; Li L; Rosenzweig A
    J Biol Chem; 2002 Jun; 277(25):22528-33. PubMed ID: 11956204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase.
    Massengill MT; Ashraf HM; Chowdhury RR; Chrzanowski SM; Kar J; Warren SA; Walter GA; Zeng H; Kang BH; Anderson RH; Moss RL; Kasahara H
    Cardiovasc Res; 2016 Jul; 111(1):34-43. PubMed ID: 27025239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connexin43 and zonula occludens-1 are targets of Akt in cardiomyocytes that correlate with cardiac contractile dysfunction in Akt deficient hearts.
    Ock S; Lee WS; Kim HM; Park KS; Kim YK; Kook H; Park WJ; Lee TJ; Abel ED; Kim J
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1183-1191. PubMed ID: 29378301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
    Lin H; Li Y; Zhu H; Wang Q; Chen Z; Chen L; Zhu Y; Zheng C; Wang Y; Liao W; Bin J; Kitakaze M; Liao Y
    Cardiovasc Res; 2020 Jan; 116(1):101-113. PubMed ID: 30689763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AKT signalling in the failing heart.
    Chaanine AH; Hajjar RJ
    Eur J Heart Fail; 2011 Aug; 13(8):825-9. PubMed ID: 21724622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.